Impact of metformin in cardiometabolic risk factors in polycystic ovary syndrome: role of race/ethnicity

被引：0
|
作者：
Chatakondi, R. N. [1 ]
Salau, F. [1 ]
Pruett, J. [2 ]
Romero, D. G. [2 ]
Cardozo, L. Yanes [2 ]
机构：
[1] Univ Mississippi, Med Ctr, Greenville, MS USA
[2] Univ Mississippi, Med Ctr, Jackson, MS USA
来源：
AMERICAN JOURNAL OF THE MEDICAL SCIENCES | 2023年 / 365卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
636
引用
收藏
页码：S347 / S348
页数：2
相关论文
共 50 条
  • [1] Impact of Metformin on Cardiometabolic risk factors in Polycystic Ovary Syndrome: Comparison between races
    Chatakondi, Raksha
    Salau, Faridah
    Pruett, Jacob
    Romero, Damien
    Yanes-Cardozo, Licy
    [J]. PHYSIOLOGY, 2023, 38
  • [2] Cardiometabolic risk factors in polycystic ovary syndrome
    Mehrabian, Ferdous
    Keramatian, Kasra
    Kelishadi, Roya
    [J]. PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2012, 28 (02) : 339 - 344
  • [3] Glucagon-like peptide-1 receptor agonists and cardiometabolic risk factors in Polycystic Ovary Syndrome: role of race/ethnicity
    Pruett, Jacob
    Romero, Damian
    Cardozo, Licy Yanes
    [J]. PHYSIOLOGY, 2023, 38
  • [4] Cardiometabolic Risk Factors in Adolescents with Polycystic Ovary Syndrome
    Vatopoulou, Anastasia
    Dionelli, Maria-Eleni
    Papanikolaou, Alexis
    Grover, Sonia
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2021, 27 (36) : 3808 - 3811
  • [5] The Impact of Atorvastatin on Cardiometabolic Risk Factors in Sisters of Women with Polycystic Ovary Syndrome
    Krysiak, Robert
    Kowalcze, Karolina
    Okopien, Boguslaw
    [J]. PHARMACOLOGY, 2023, 108 (05) : 451 - 459
  • [6] The impact of atorvastatin on cardiometabolic risk factors in brothers of women with polycystic ovary syndrome
    Robert Krysiak
    Witold Szkróbka
    Bogusław Okopień
    [J]. Pharmacological Reports, 2021, 73 : 261 - 268
  • [7] Impact of Lisinopril on Cardiometabolic Risk Factors in Sisters of Women With Polycystic Ovary Syndrome
    Krysiak, Robert
    Kowalcze, Karolina
    Okopien, Boguslaw
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 63 (09): : 1045 - 1052
  • [8] The impact of atorvastatin on cardiometabolic risk factors in brothers of women with polycystic ovary syndrome
    Krysiak, Robert
    Szkrobka, Witold
    Okopien, Boguslaw
    [J]. PHARMACOLOGICAL REPORTS, 2021, 73 (01) : 261 - 268
  • [9] Cardiometabolic risk in polycystic ovary syndrome
    Studen, Katica Bajuk
    Pfeifer, Marija
    [J]. ENDOCRINE CONNECTIONS, 2018, 7 (07): : R238 - +
  • [10] Correction to: The impact of atorvastatin on cardiometabolic risk factors in brothers of women with polycystic ovary syndrome
    Robert Krysiak
    Witold Szkróbka
    Bogusław Okopień
    [J]. Pharmacological Reports, 2021, 73 : 1481 - 1481
12345